ReferenceID 1538
Chrysophanol ameliorates renal interstitial fibrosis by inhibiting the TGF-β/Smad signaling pathway
Biochem Pharmacol
Renal interstitial fibrosis (RIF) is a major pathological feature of chronic kidney disease at middle and end stages. Chrysophanol (CP), 1,8-dihydroxy-3-methyl-9,10-anthraquinone, is an anthraquinone isolated from Rheum
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Ingredient: 1Reference: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final reference record.
- Reference Id
- 1538
- Evidence Id
- 18128
- Core Evidence Id
- 18128
- Source Reference Id
- 3069
- Herb2 Reference Id
- HBREF003866
- Subject Paper Key
- HBIN020479_32511988
- Pubmed Id
- 32511988
- Doi
- 10.1016/j.bcp.2020.114079
- Paper Title
- Chrysophanol ameliorates renal interstitial fibrosis by inhibiting the TGF-β/Smad signaling pathway
- Paper Abstract
- Renal interstitial fibrosis (RIF) is a major pathological feature of chronic kidney disease at middle and end stages. Chrysophanol (CP), 1,8-dihydroxy-3-methyl-9,10-anthraquinone, is an anthraquinone isolated from Rheum palmatum L. with a variety of pharmacological activities including the suppression of RIF. However, the effect of CP on renal fibrosis and its potential mechanism have not been elucidated. We conducted a comprehensive study by determining the expression levels of fibrotic markers and proteins including TGF-beta1, alpha-SMA, and Smad3 related to transforming growth factor-beta/Smad (TGF-beta/Smad) pathway in unilateral ureteral obstruction (UUO) mice and TGF-beta1-stimulated HK-2 cells with the treatment of CP using western blotting and RT-qPCR analyses. Using small interfering RNA and co-immunoprecipitation, we evaluated the influences of CP on the interactions between Smad3 and Smad7 proteins and also on TGF-beta RI and TGF-betaR II. We found that CP administration significantly ameliorated UUO-induced kidney damage by reversing abnormal serum and urine biochemical parameters and decreasing the production of fibrotic markers including collagen I, collagen III, fibronectin, and alpha-SMA. Our results showed that TGF-beta1 and phospho-Smad3 (p-Smad3) expression was significantly down-regulated and Smad7 expression was up-regulated by CP in UUO mice compared to the model group; however, the expression of Smad2, Smad4, and TGF-beta receptors was not affected. Furthermore, CP modulated these fibrotic markers as well as p-Smad3 and Smad7 in TGF-beta1-induced HK-2 cells. The inhibitory effect of CP was markedly reduced in TGF-beta1-treated HK-2 cells transfected with Smad3 siRNA. Additionally, co-immunoprecipitation analysis indicated that CP blocked the interaction between Smad3 and TGF-beta receptor I to suppress p-Smad3 expression. These findings demonstrated that CP alleviated RIF by inhibiting Smad3 phosphorylation, which provides a molecular basis for a new drug candidate for the treatment of RIF.
- Journal
- Biochem Pharmacol
- Publish Year
- 2020
- Experiment Subject
- mouse; tgf-beta1-induced hk-2 cells; tgf-beta1-stimulated hk-2 cells; tgf-beta1-treated hk-2 cells
- Experiment Type
- Animal & Cell Experiment
- Phenotype Related
- Chronic Kidney Disease; Renal Fibrosis; Renal Interstitial Fibrosis; Unilateral Ureteral Obstruction
- Paper Title Cn
- Paper Title En
- Chrysophanol ameliorates renal interstitial fibrosis by inhibiting the TGF-β/Smad signaling pathway
- Bilingual Status
- semi_complete